JPMorgan Reinstates Stoke Therapeutics (STOK) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: STOK) | Delayed: 26.13 +0.67 (2.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.46 | 52 Week High | $ | |||
| Open | $25.44 | 52 Week Low | $ | |||
| Day High | $26.35 | P/E | N/A | |||
| Day Low | $25.22 | EPS | $ | |||
| Volume | 1,325,216 | |||||
